overseas

Bringing life to life is a belief; it knows no boundaries. In early 2000 we began expanding our pharmaceutical horizons through our work in deep science. Today we have successfully augmented our competencies in biological, biosimilars and complex generics by entering product alliances and strategic tie-ups.

We have wholly-owned subsidiaries in USA, Germany, Malaysia and the Philippines. Our team in Germany manufactures therapeutic proteins derived from natural sources. Our US-based research and drug development organisation is dedicated to early stage development of recombinant molecules.

With operations in Russia, Ukraine, LATAM, Middle East, Africa and SEA countries, we have built business efficiencies for our partner companies across the globe. Our 300 member team across the globe has made a measurable impact to health and quality of life globally.